Petra Kaufmann

7.6k total citations
86 papers, 3.4k citations indexed

About

Petra Kaufmann is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Petra Kaufmann has authored 86 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 34 papers in Genetics and 20 papers in Neurology. Recurrent topics in Petra Kaufmann's work include Neurogenetic and Muscular Disorders Research (34 papers), Mitochondrial Function and Pathology (15 papers) and Amyotrophic Lateral Sclerosis Research (13 papers). Petra Kaufmann is often cited by papers focused on Neurogenetic and Muscular Disorders Research (34 papers), Mitochondrial Function and Pathology (15 papers) and Amyotrophic Lateral Sclerosis Research (13 papers). Petra Kaufmann collaborates with scholars based in United States, Canada and United Kingdom. Petra Kaufmann's co-authors include Douglas M. Sproule, Darryl C. De Vivo, Salvatore DiMauro, Ali Naini, Jacqueline Montes, Christopher P. Austin, Hiroshi Mitsumoto, Kristin Engelstad, Richard S. Finkel and Sara Shanske and has published in prestigious journals such as Nature Medicine, PLoS ONE and Neurology.

In The Last Decade

Petra Kaufmann

86 papers receiving 3.3k citations

Peers

Petra Kaufmann
Petra Kaufmann
Citations per year, relative to Petra Kaufmann Petra Kaufmann (= 1×) peers Janbernd Kirschner

Countries citing papers authored by Petra Kaufmann

Since Specialization
Citations

This map shows the geographic impact of Petra Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Kaufmann more than expected).

Fields of papers citing papers by Petra Kaufmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Kaufmann. The network helps show where Petra Kaufmann may publish in the future.

Co-authorship network of co-authors of Petra Kaufmann

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Kaufmann. A scholar is included among the top collaborators of Petra Kaufmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Kaufmann. Petra Kaufmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reoma, Lauren, Ania Busza, M. Maral Mouradian, et al.. (2022). Experimental Neurotherapeutics: Surfing the Tidal Wave of New Opportunities. Annals of Neurology. 93(3). 427–430. 1 indexed citations
2.
Chand, Deepa H., F. Mohr, Hugh J. McMillan, et al.. (2020). Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy. Journal of Hepatology. 74(3). 560–566. 196 indexed citations
3.
Leonard, Helen, Tim A. Benke, Pamela S. Diener, et al.. (2019). Establishing Clinical Trial Readiness of the Rett Syndrome Hand Function Measure (P1.6-034). Neurology. 92(15_supplement). 2 indexed citations
4.
Heslop, Emma, Cristina Csimma, Volker Straub, et al.. (2015). The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development. Orphanet Journal of Rare Diseases. 10(1). 49–49. 16 indexed citations
5.
Kaufmann, Petra & P. Pearl O’Rourke. (2014). Central Institutional Review Board Review for an Academic Trial Network. Academic Medicine. 90(3). 321–323. 18 indexed citations
6.
Reich‐Slotky, Ronit, Jinsy Andrews, Richard Buchsbaum, et al.. (2013). Body Mass Index (BMI) as Predictor of ALSFRS-r Score Decline in ALS Patients (P07.085). Neurology. 80(7_supplement). 1 indexed citations
7.
Kang, Peter B., Clifton L. Gooch, Michael McDermott, et al.. (2013). The motor neuron response to SMN1 deficiency in spinal muscular atrophy. Muscle & Nerve. 49(5). 636–644. 28 indexed citations
8.
Crawford, Thomas O., Sergey Paushkin, Dione Kobayashi, et al.. (2012). Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study. PLoS ONE. 7(4). e33572–e33572. 119 indexed citations
9.
Glanzman, Allan M., Michael McDermott, Jacqueline Montes, et al.. (2011). Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatric Physical Therapy. 23(4). 322–326. 95 indexed citations
10.
Conwit, Robin, Minal Bhanushali, John D. Porter, Petra Kaufmann, & Laurie Gutmann. (2011). Adding more muscle and nerve to clinical trials. Muscle & Nerve. 44(5). 695–702. 4 indexed citations
11.
Weimer, Louis H., Kristin Engelstad, Vanessa Battista, et al.. (2010). Autonomic Symptoms in Carriers of the m.3243A>G Mitochondrial DNA Mutation. Archives of Neurology. 67(8). 976–9. 18 indexed citations
12.
Buchsbaum, Richard, Petra Kaufmann, Alexandra I. Barsdorf, et al.. (2009). Web-based data management for a phase II clinical trial in ALS. Amyotrophic Lateral Sclerosis. 10(5-6). 374–377. 9 indexed citations
13.
Sproule, Douglas M., Jacqueline Montes, Megan Montgomery, et al.. (2009). Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy. Neuromuscular Disorders. 19(6). 391–396. 73 indexed citations
14.
Hinton, Veronica J., Shana E. Cyrulnik, Robert J. Fee, et al.. (2009). Association of Autistic Spectrum Disorders With Dystrophinopathies. Pediatric Neurology. 41(5). 339–346. 60 indexed citations
15.
Tanji, Kurenai, Petra Kaufmann, Ali Naini, et al.. (2008). A novel tRNAVal mitochondrial DNA mutation causing MELAS. Journal of the Neurological Sciences. 270(1-2). 23–27. 18 indexed citations
16.
Oskoui, Maryam & Petra Kaufmann. (2008). Spinal Muscular Atrophy. Neurotherapeutics. 5(4). 499–506. 45 indexed citations
17.
Rafay, Mubeen F., E. Gordon Murphy, Julie McGarry, et al.. (2005). Clinical and Biochemical Heterogeneity in an Italian Family with CPT II Deficiency due to Ser 113 Leu Mutation. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 32(3). 316–320. 5 indexed citations
18.
Naini, Ali, Jiesheng Lu, Petra Kaufmann, et al.. (2005). Novel Mitochondrial DNA ND5 Mutation in a Patient With Clinical Features of MELAS and MERRF. Archives of Neurology. 62(3). 473–473. 55 indexed citations
19.
Leung, Conrad L., Petra Kaufmann, Steven Chin, et al.. (2004). A Pathogenic Peripherin Gene Mutation in a Patient with Amyotrophic Lateral Sclerosis. Brain Pathology. 14(3). 290–296. 76 indexed citations
20.
Louis, Elan D., Livia F. Barnes, Kristin J. Wendt, et al.. (2001). A teaching videotape for the assessment of essential tremor. Movement Disorders. 16(1). 89–93. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026